Raven Biosciences provides in-silico molecular design services and platforms spanning small molecules, peptides, antibodies, enzymes, and nucleotides. Offerings include structure-based optimization, epitope characterization, and ML-driven screening, helping organizations accelerate discovery programs and generate predictive models for target and lead selection.